Evidence map›Paper›PMID 17292337›Full record

ArticleBrain research2007

Effects of NGF and BDNF on baseline glutamate and dopamine release in the hippocampal formation of the adult rat.

D Paredes, A-Ch Granholm, P C Bickford

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Association between smoking, nicotine dependence, and BDNF Val66Met polymorphism with BDNF concentrations in serum.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  16. Article
  17. Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

D ParedesJames A. Haley, Veterans Administration Hospital, Tampa, FL, USA.
A-Ch Granholm
P C Bickford
Florida College · USJames A. Haley Veterans' Hospital · USMedical University of South Carolina · US

Funding

STATISTICAL COREP01AG004418 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI BICKFORD, PAULA C · 1985 to 2010
$11.6M
An animal model for age-related degenerationR01AG012122 · NIA · UNIVERSITY OF COLORADO DENVER · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER · 1994 to 2010
$2.8M
MECHANISMS OF NGF-INDUCED COGNITIVE IMPROVEMENT IN AGINGR01AG010755 · NIA · UNIVERSITY OF COLORADO DENVER · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER · 1991 to 2007
$2.0M
NIA NIH HHS AG04418NIA NIH HHS AG10755NIA NIH HHS P01 AG004418NIA NIH HHS R01 AG010755NIA NIH HHS R01 AG012122
6 · The paper itself

Abstract

It has been shown using in vitro techniques that BDNF and NGF evoke neurotransmitter release in the hippocampus but this phenomenon has not been demonstrated in vivo to date. We therefore performed in vivo microdialysis in urethane-anesthetized Fischer 344 rats. The microdialysis probe was implanted stereotaxically into the CA1 area of the hippocampus. Three hours after the implantation of the probe, glutamate (Glu) and dopamine (DA) levels had reached a stable baseline. Four baseline samples were collected every 15 min at a flow rate of 1 microL/min. The growth factors were delivered (1 microL/10 min) using a microinjector attached to the microdialysis probe. We found that BDNF and NGF, when administered into the hippocampus, evoked dopamine and glutamate release in a dose-dependent fashion. NGF produced a biphasic response in the release of Glu, and a uniphasic response in the release of DA, both of which were calcium dependent. The neurotransmitter release induced by NGF was blocked by tetrodotoxin, indicating neuronal origin of this response. The BDNF induced release of DA and Glu was decreased in low calcium conditions, indicating that it is at least partially calcium dependent. Furthermore, BDNF-induced neurotransmitter release was partially blocked by pre-treatment with K252a, an antagonist for tyrosine kinase receptors, indicating that BDNF is acting through Trk receptors to induce neurotransmitter release. These results demonstrate a close relationship between the growth factors BDNF and NGF and the neurotransmitters DA and Glu in the hippocampus of intact animals.

Indexed as

AnimalsArea Under CurveBrain-Derived Neurotrophic FactorCarbazolesChromatography, High Pressure LiquidDopamineDrug InteractionsElectrochemistryEnzyme InhibitorsGlutamic AcidHippocampusIndole AlkaloidsMaleMicrodialysisNerve Growth FactorRatsBrain-Derived Neurotrophic FactorCarbazolesDopamineEnzyme InhibitorsGlutamic AcidIndole AlkaloidsNerve Growth Factorstaurosporine aglycone

Identifiers

PMID17292337
PMCPMC2692481
OpenAlexW2049299981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.